Eli Lilly and Company
corporate_fare Company Profile
Eli Lilly and Company (NYSE:LLY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 161 items for LLY at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Eli Lilly Reports Strong Q4 2025 Results, Driven by Mounjaro and Zepbound, Issues Robust 2026 Guidance
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$65.18B
Net Income
$20.64B
Diluted EPS
$22.95
Op. Cash Flow
$16.81B
Gross Profit
$54.13B
Cash & Equivalents
$7.27B
Total Debt
$42.5B
Debt / Equity
1.60×
Net Margin
31.7%
Shares Outstanding
897.3M sh
Source: 10-K · filed 2026-02-12 · accession 0000059478-26-000013
show_chartPrice Chart
Loading chart...
feed LLY - Filings & News (Page 9)
LLY
Feb 04, 2026, 7:05 AM EST
Price at Filing:
$1,071.07
Real-time Price:
$1,348.06
Change:
+$276.99 (+26%)
Market Cap:
$1.267T